Skip to Main Content
Pharmacy Technician's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • National Certification
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Respiratory & Allergy
  4. COPD

COPD

  • Allergic Reactions (123)
  • Allergic Rhinitis (54)
  • Asthma (149)
  • Autoimmune Disorders (3)
  • COPD (117)
    • Immunizations (30)
    • Interactions (8)
    • Treatment (94)
  • Cystic Fibrosis (4)
  • Ear Health (13)
  • Ear, Nose & Throat (36)
  • E-Cigarettes (1)
  • Immunology (3)
  • Inhalers (33)
  • Other (14)
  • Otolaryngology (20)
  • Pulmonary (11)
  • Resources (232)
  • Respiratory Infections (359)
  • Sleep Apnea (12)
  • Smoking (19)
  • Smoking Cessation (106)
61 - 75 of 117 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: avoiding mishaps with tablets and capsules that should NOT be swallowed November 2013
Commentary: Beta-Blockers and COPD August 2013
Commentary: Corticosteroids for COPD Exacerbation August 2013
Article: changes in the treatments used for chronic obstructive pulmonary disease (COPD) August 2013
Commentary: Antivirals in the Prevention and Treatment of Influenza February 2013
Chart: Potential Drug Interactions with Grapefruit January 2013
Article: Tudorza Pressair (TU-door-za, aclidinium), for chronic obstructive pulmonary disease (COPD) December 2012
Commentary: Tudorza Pressair (Aclidinium) December 2012
Commentary: New Formulation: Combivent Respimat September 2012
Article: Combivent Respimat (ipratropium/albuterol) September 2012
Article: more asthma and more Rxs for asthma inhalers February 2012
Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease UPDATED 2010 January 2012
Commentary: New Drug: Arcapta (Indacaterol) January 2012
Article: a new inhaler, Arcapta (indacaterol, ar-CAP-ta), for patients with chronic obstructive pulmonary disease (COPD) January 2012
Commentary: Market Withdrawal of Primatene Mist (Epinephrine) Inhalers November 2011
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved